Condition
Insight Impaired
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03140475Completed
Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition
NCT06177262UnknownPrimary
Characteristics of Illness Awareness in Anorexia Nervosa
NCT04038788Not ApplicableCompleted
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia
NCT03701100Not ApplicableCompleted
The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia
Showing all 4 trials